The WT1 has been reported to be overexpressed in a variety of tumors, including leukemia, breast cancer, and pediatric kidney tumors (Wilms' tumor) and to play an oncogenic role in other cancer types including renal and bladder cancer8–10. Here, WT1 is linked to cancer.